Literature DB >> 9577775

Natural Mycoplasma gallisepticum infection in a captive flock of house finches.

M P Luttrell1, D E Stallknecht, J R Fischer, C T Sewell, S H Kleven.   

Abstract

Naturally-occurring mycoplasmal conjunctivitis is described among 104 wild-caught, and initially seronegative, house finches (Carpodacus mexicanus) maintained in captivity for 12 wk during November 1995 through January 1996. Finches housed in three pens were monitored for clinical signs, and > or = 10 birds were euthanatized for necropsy and mycoplasma testing every 2 wk. Within 2 to 4 wk following initial detection of lesions, > 50% of the birds in each of three pens developed a debilitating disease characterized by mild to severe ocular swelling, conjunctivitis, and ocular and nasal discharge. Microscopic lesions in affected finches consisted of mild to severe lymphoplasmacytic inflammation with epithelial and lymphoid hyperplasia in conjunctivae, nasal turbinates, and trachea. Mycoplasma gallisepticum infection was confirmed by culture or polymerase chain reaction (PCR) in all birds with conjunctival lesions and in 43% of birds without lesions. An arbitrary primer PCR was used to confirm M. gallisepticum isolates as identical to a field strain previously associated with house finch conjunctivitis. Most birds (89%) with conjunctivitis developed a concurrent antibody response detectable by serum plate agglutination (SPA) within 2 wk of lesion development. Hemagglutination inhibition (HI) and enzyme-linked immunosorbent assay (ELISA) tests were less sensitive than the SPA test. The clinical severity of this disease and high proportion of affected birds suggests that M. gallisepticum may have a negative impact on free-flying house finch populations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577775     DOI: 10.7589/0090-3558-34.2.289

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  8 in total

1.  Density-dependent decline of host abundance resulting from a new infectious disease.

Authors:  W M Hochachka; A A Dhondt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Deposition of pathogenic Mycoplasma gallisepticum onto bird feeders: host pathology is more important than temperature-driven increases in food intake.

Authors:  James S Adelman; Amanda W Carter; William A Hopkins; Dana M Hawley
Journal:  Biol Lett       Date:  2013-08-21       Impact factor: 3.703

3.  Evidence of trade-offs shaping virulence evolution in an emerging wildlife pathogen.

Authors:  P D Williams; A P Dobson; K V Dhondt; D M Hawley; A A Dhondt
Journal:  J Evol Biol       Date:  2014-04-18       Impact factor: 2.411

4.  Rapid evolution of disease resistance is accompanied by functional changes in gene expression in a wild bird.

Authors:  Camille Bonneaud; Susan L Balenger; Andrew F Russell; Jiangwen Zhang; Geoffrey E Hill; Scott V Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-27       Impact factor: 11.205

5.  Eye of the Finch: characterization of the ocular microbiome of house finches in relation to mycoplasmal conjunctivitis.

Authors:  Courtney A Thomason; Ariel Leon; Laila T Kirkpatrick; Lisa K Belden; Dana M Hawley
Journal:  Environ Microbiol       Date:  2017-01-25       Impact factor: 5.491

6.  Feeder density enhances house finch disease transmission in experimental epidemics.

Authors:  Sahnzi C Moyers; James S Adelman; Damien R Farine; Courtney A Thomason; Dana M Hawley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-05-05       Impact factor: 6.237

7.  Development and validation of a house finch interleukin-1β (HfIL-1β) ELISA system.

Authors:  Sungwon Kim; Myeongseon Park; Ariel E Leon; James S Adelman; Dana M Hawley; Rami A Dalloul
Journal:  BMC Vet Res       Date:  2017-08-30       Impact factor: 2.741

8.  Occurrence of Mycoplasma gallisepticum in wild birds: A systematic review and meta-analysis.

Authors:  Anna Sawicka; Maciej Durkalec; Grzegorz Tomczyk; Olimpia Kursa
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.